Nihon Kohden Corporation (6849)

Name: Nihon Kohden Corporation (6849) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-09-21

Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters.

Números-chave

Capitalização de mercado: JPY 254 billion
Receita (exercício encerrado em 2026-03-31): JPY 235.1B
Lucro líquido: JPY 14.5B
Margem bruta: 51.8%
Margem líquida: 6.2%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Receita total	JPY 235.1B	JPY 225.4B	JPY 222.0B	JPY 206.6B	—
Lucro bruto	JPY 121.7B	JPY 117.2B	JPY 111.3B	JPY 105.9B	—
Resultado Operacional (EBIT)	JPY 18.7B	JPY 20.7B	JPY 19.6B	JPY 21.1B	—
Resultado líquido	JPY 14.5B	JPY 14.1B	JPY 17.0B	JPY 17.1B	—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 6849. /companies/us/6849

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.